Moderna (NASDAQ: MRNA) stock jumped almost 5% on Wednesday and hits a new all-time of $249.
The key technical levels to watch: $260 and $225/10.
“These new data are encouraging and reinforce our belief that the Moderna Covid-19 vaccine should remain protective against newly detected variants.” - Moderna CEO, Stephane Bancel said last month.